Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)

• Egile Nagusiak: Tangui Barré (Egilea), Hélène Fontaine (Egilea), Stanislas Pol (Egilea), Clémence Ramier (Egilea), Vincent Di Beo (Egilea), Camelia Protopopescu (Egilea), Fabienne Marcellin (Egilea), Morgane Bureau (Egilea), Marc Bourlière (Egilea), Céline Dorival (Egilea), Ventzislava Petrov-Sanchez (Egilea), Tarik Asselah (Egilea), Elisabeth Delarocque-Astagneau (Egilea), Dominique Larrey (Egilea), Jean-Charles (Egilea), Fabrice Carrat (Egilea), Patrizia Carrieri (Egilea), on behalf of the ANRS/AFEF Hepather Study Group (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

People living with chronic hepatitis B virus (HBV) infection are at high risk of liver disease progression, which is positively associated with metabolic disorders, but inversely associated with dyslipidemia. Diet, including dietary antioxidants, is a lever of metabolic disorder management. In parti...